Survival predictors in biopsy-proven giant cell arteritis: a northern Italian population-based study

Author:

Macchioni Pierluigi1,Boiardi Luigi1,Muratore Francesco2,Restuccia Giovanna1,Cavazza Alberto1,Pipitone Nicolò1,Catanoso Mariagrazia1,Mancuso Pamela3,Luberto Ferdinando3,Giorgi Rossi Paolo3,Salvarani Carlo2

Affiliation:

1. Rheumatology Unit, Department of Specialistic Medicine, and Pathology Unit, Department of Oncology and Advanced Technology, Azienda USL-IRCCS di Reggio Emilia, Italy

2. Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Italy

3. Interinstitutional Epidemiology Unit, Azienda USL-IRCCS di Reggio Emilia (Local Health Authority), Reggio Emilia, Italy

Abstract

Abstract Objective To evaluate the influence of disease-related findings and treatment outcomes on survival in a population-based cohort of Northern Italian patients with GCA. Methods A total of 281 patients with incident temporal artery biopsy (TAB)-proven GCA, diagnosed over a 26-year period (1986–2012) and living in the Reggio Emilia area, were retrospectively evaluated. We analysed clinical, imaging and laboratory findings at diagnosis, pathological patterns of TAB, CS treatment and therapeutic outcomes, and traditional cardiovascular risk factors as factors predictive of survival. Results Univariate analysis showed that increased mortality was associated with large vessel involvement at diagnosis [hazard ratio (HR) 5.84], while reduced mortality was associated with female sex (HR 0.66), PMR (HR 0.54), higher haemoglobin levels (HR 0.84) at diagnosis, long-term remission (HR 0.47) and inflammation limited to adventitia or to the adventitial vasa vasorum (HR 0.48) at TAB examination. Multivariate analysis confirmed the association between increased mortality and large vessel involvement (HR 5.14) at diagnosis, between reduced mortality and PMR (HR 0.57) at diagnosis and adventitial inflammation (HR 0.31) at TAB. Conclusion PMR at diagnosis and inflammation limited to the adventitia at TAB appear to identify subsets of patients with more benign disease, while large vessel involvement at diagnosis is associated with reduced survival.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference42 articles.

1. Polymyalgia rheumatica and giant-cell arteritis;Salvarani;Lancet,2008

2. Incidence and survival rate in cases of biopsy-proven temporal arteritis;Rajala;Scand J Rheumatol,1993

3. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period;Salvarani;Arthritis Rheum,2004

4. Mortality in patients with biopsy-proven giant cell arteritis: a south Australian population-based study;Ninan;J Rheumatol,2011

5. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality;González-Gay;J Rheumatol,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3